Inventor · disambiguated record
Jaimie Karyn Rueter
Also filed as: RUETER JAIMIE K · RUETER JAIMIE KARYN
24 granted patents·6 pending applications·175 citations·filing 2002–2025
96Inventor score
Files withARENA PHARM INC19NEUROCRINE BIOSCIENCES INC4BLACKBURN ANTHONY C2THATTE JAYANT2BRISTOL MYERS SQUIBB CO1
Top patents by PatentIndex Score
30 records- 0197US11091435B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in S1P1 receptor-associated disordersARENA PHARM INC·Filed 2020·Granted Aug 17, 2021·11 cites·15 claims
- 0297US10676435B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound 1) for use in SIPI receptor-associated disordersARENA PHARM INC·Filed 2019·Granted Jun 9, 2020·12 cites·25 claims
- 0396US11884626B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1P1 receptor-associated disordersARENA PHARM INC·Filed 2021·Granted Jan 30, 2024·3 cites·16 claims
- 0496US11771695B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2021·Granted Oct 3, 2023·4 cites·11 claims
- 0594US11560369B2Crystalline forms and processes for the preparation of cannabinoid receptor modulatorsARENA PHARM INC·Filed 2021·Granted Jan 24, 2023·2 cites·20 claims
- 0693US10981895B2Crystalline forms and processes for the preparation of cannabinoid receptor modulatorsARENA PHARM INC·Filed 2018·Granted Apr 20, 2021·4 cites·16 claims
- 0793US10301262B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disordersARENA PHARM INC·Filed 2016·Granted May 28, 2019·11 cites·50 claims
- 0893US10183930B2Crystalline forms and processes for the preparation of cannabinoid receptor modulatorsARENA PHARM INC·Filed 2016·Granted Jan 22, 2019·10 cites·11 claims
- 0993US9458136B2Crystalline forms and processes for the preparation of cannabinoid receptor modulatorsBLACKBURN ANTHONY C·Filed 2012·Granted Oct 4, 2016·11 cites·34 claims
- 1092US10632134B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2017·Granted Apr 28, 2020·5 cites·16 claims
- 1191US9867822B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2016·Granted Jan 16, 2018·7 cites·18 claims
- 1291US9492447B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2015·Granted Nov 15, 2016·9 cites·20 claims
- 1390US12378198B2Crystalline l-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in SIPI receptor-associated disordersARENA PHARM INC·Filed 2023·Granted Aug 5, 2025·0 cites·40 claims
- 1489US2025346560A1Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in sipi receptor-associated disordersARENA PHARM INC·Filed 2025·Application pending·0 cites
- 1588US9597340B2Cannabinoid receptor modulatorsTHATTE JAYANT·Filed 2012·Granted Mar 21, 2017·9 cites·17 claims
- 1687US7229995B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2005·Granted Jun 12, 2007·10 cites·20 claims
- 1782US6924284B2PARP inhibitorsDELTAGEN RES LABS LLC·Filed 2002·Granted Aug 2, 2005·42 cites·55 claims
- 1880US7015226B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Granted Mar 21, 2006·12 cites·28 claims
- 1975US9248133B2Salts of lorcaserin with optically active acidsBLACKBURN ANTHONY C·Filed 2011·Granted Feb 2, 2016·3 cites·24 claims
- 2075US7329669B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2006·Granted Feb 12, 2008·2 cites·20 claims
- 2173US7071200B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Granted Jul 4, 2006·6 cites·39 claims
- 2272US10226471B2Modified-release dosage forms of 5-HT2C agonists useful for weight managementARENA PHARM INC·Filed 2017·Granted Mar 12, 2019·1 cites·7 claims
- 2367US7459474B2Modulators of the glucocorticoid receptor and methodBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Dec 2, 2008·1 cites·16 claims
- 2467US2020069681A1Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2019·Application pending·0 cites
- 2564US12109219B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2020·Granted Oct 8, 2024·0 cites·20 claims
- 2663US2018280386A1Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2017·Application pending·0 cites
- 2759US10463676B2Modified-release dosage forms of 5-HT2C agonists useful for weight managementARENA PHARM INC·Filed 2019·Granted Nov 5, 2019·0 cites·15 claims
- 2855US2014206649A1Cannabinoid receptor modulatorsTHATTE JAYANT·Filed 2012·Application pending·0 cites
- 2947US2013315994A1Modified-release dosage forms of 5-ht2c agonists useful for weight managementSHAO ZEZHI JESSE·Filed 2011·Application pending·0 cites
- 3041US2016151381A1Salts of lorcaserin with optically active acidsARENA PHARM INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jaimie Karyn Rueter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →